RxDoctor Payments Data

Nicholas Debellis, MD

Orthopaedic Surgery · New York, NYNPI 1467863142

Payments from drug & device makers

What this record shows

This record is dominated by grants: $30,000 of the $39,620 with a category attached, or 75.7%. Arthrex accounts for 84.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $21,758 and has fallen 89.2% since, to $2,348 in 2025.

$39,620in general payments, 2019–2025

Across 71 payments — averaging $558.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$33K
  • Goode Surgical Inc$1K
  • Micromed Inc$1K
  • Stryker$1K
  • Gotham Surgical Solutions & Devices, Inc.$922
  • Exactech, Inc.$370
  • plus $1K from 13 others

What the payments were for

  • Grants$30,00076%
  • Travel & lodging$2,6167%
  • Food & beverage$3,2478%
  • Education$3,7569%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,620 in reported general payments places this provider in the 80th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$175,846
Medicare patients
415
Services billed
1,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium45$377
Methylprednisolone35$231
Meloxicam93$212
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen35$138
Gabapentin11$118
Cyclobenzaprine Hcl32$107
Ibuprofen17$77
Naproxen12$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →